Shandong Xinhua Pharmaceutical 'H'

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for central nervous system diseases; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine for decoction, traditional Chinese medicines, chemical raw materials, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, the company offers materials and intermediates, powders for injection and tablets, and bulk pharmaceutical and intermediates; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Shandong Xinhua Pharmaceutical Company Limited also engages in the certification, import, and export business; real estate business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as sales of mechanical, hardware, and electrical equipment. Further, it produces and sells high-end steroid system APIs and intermediates; and provides internet data services, internet sales, and internet information services for pharmaceuticals and medical devices, etc. The company operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.